News & Events





  • Vivasure Medical to present their PerQseal technology at PCR London Valves 2017

    Galway, Ireland – September 19, 2017 – Vivasure Medical is pleased to announce that Dr. Michael Laule, from the Charite Hospital in Berlin Germany, will deliver a presentation on its PerQseal technology on Monday 25th September at 17:20h during the session “Percutaneous valve intervention: new devices, new approaches” at PCR London Valves, which will be held at London’s ExCel from 24th -26th September2017.

    Vivasure will also be exhibiting at PCR London Valves which is the leading European Heart Team course, focusing on transcatheter therapies for valvular heart disease.

    About Vivasure Medical

    Vivasure Medical Limited is a highly innovative medical device company based in the heart of Europe’s largest medtech hub in Galway, Ireland. The company develops advanced polymer implants and delivery systems, primarily focused on minimally invasive vessel closure in cardiology, interventional radiology and vascular surgery.

    Based on its patented PerQseal® technology, Vivasure has developed the world’s first fully absorbable, patch-based large-bore percutaneous closure devices. These new devices enable safe and reliable closure of large areriotomies in transcatheter procedures such as those used for Transcatheter Aortic Valve Replacement (TAVR) and Endovascular Anuerysm Repair (EVAR).

    Download in PDF format